Haemodynamic changes after high-volume plasmapheresis in patients with chronic and acute liver failure

Eur J Gastroenterol Hepatol. 1997 Jan;9(1):55-60. doi: 10.1097/00042737-199701000-00014.

Abstract

Objective: To evaluate the haemodynamic changes during treatment with high-volume plasmapheresis in patients with chronic liver failure compared to patients with acute liver failure.

Methods: Haemodynamic measurements were performed with a Swan-Ganz catheter and thermodilution technique. High-volume plasmapheresis (mean plasma exchange of 8.6 litres) was performed in 11 patients with chronic and 16 patients with acute liver failure.

Results: In patients with chronic liver failure, systemic vascular resistance index was unaltered: 1193 +/- 494 dynscm-5m2 before treatment versus 1180 +/- 399 dynscm-5m2 after. Mean arterial pressure increased from 69 +/- 11 mmHg to 78 +/- 13 mmHg (P < 0.05) and cardiac output increased from 8.1 +/- 2.4 l/min to 8.9 +/- 2.4 l/min (P < 0.05) during high-volume plasmapheresis. In patients with acute liver failure, systemic vascular resistance index increased from 1154 +/- 628 dynscm-5m2 to 1614 +/- 738 dynscm-5m2 (P < 0.001). In this group mean arterial pressure increased from 78 +/- 16 mmHg to 95 +/- 10 mmHg (P < 0.001) and cardiac output decreased from 9.6 +/- 3.7 l/min to 8.2 +/- 2.9 l/min (P < 0.01).

Conclusion: The hyperkinetic circulation in chronic and acute patients was differently affected by high-volume plasmapheresis. We suggest that in chronic liver failure both portosystemic shunting and chronic peripheral vasodilation may contribute to the hyperkinetic syndrome, whereas in acute liver failure a humoral factor which can be removed by high-volume plasmapheresis is a main contributor.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Bilirubin / blood
  • Blood Gas Analysis
  • Catheterization, Central Venous
  • Chronic Disease
  • Female
  • Hemodynamics / physiology
  • Hemoglobins / metabolism
  • Humans
  • Liver Circulation
  • Liver Failure / blood
  • Liver Failure / physiopathology*
  • Liver Failure / therapy
  • Male
  • Middle Aged
  • Plasmapheresis*
  • Respiration, Artificial
  • Treatment Outcome

Substances

  • Hemoglobins
  • Bilirubin